Context: Non-communicable diseases, including hypertension, are major causes of complications during pregnancy, posing significant risks to maternal and fetal health. Pregnancy increases cardiovascular risks, particularly through the development of gestational hypertension and preeclampsia, requiring early screening and close monitoring to prevent adverse outcomes. Objectives: This study aimed to evaluate the frequency of cardiovascular risk factors in pregnant women in Senegal and identify associated socio-behavioral and economic determinants. Methodology: A descriptive, analytical cross-sectional study with prospective data collection was conducted over three months (April 10 to July 10, 2023). The study included pregnant women aged 15 and older from three public hospital maternity wards in Senegal. We studied sociodemographic aspects, cardiovascular risk factors, and collected information on previous and current pregnancies, including the number of pregnancies, parity, miscarriages, the number of prenatal consultations, and the number of fetuses. Written consent was obtained. A p-value ≤ 0.05 was considered statistically significant. Results: A total of 222 pregnant women were enrolled, representing 28% of prenatal consultations. The average age was 29.18 years (range 15 - 47). Most participants (90%) lived in Dakar suburbs, 74.20% had no medical coverage, 84% worked in the informal sector (p = 0.043), and 18% had no education. Among them, 30.63% were in their first pregnancy, 34% were nulliparous, and 3.15% were grand multiparous. The average number of prenatal visits was 3.5, with about 40% having more than four visits. Risk factors included hypertension (17%), more prevalent in women over 30 (p = 0.043), diabetes (4%), and smoking (2%). Conclusion: The study highlights critical prenatal health needs and socio-economic challenges faced by pregnant women, emphasizing the need for targeted strategies to improve healthcare access and health education.
References
[1]
Organisation Mondiale de la Santé (2017) Maladie cardiovasculaire dans le monde. https://www.who.int/fr/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
[2]
Anderson, K. (1997) Les jeunes, l’alcool, la drogue et le tabac. OMS, Publications régionales, Série européenne.
[3]
Chen, J., Cox, S., Kuklina, E.V., Ferre, C., Barfield, W. and Li, R. (2021) Assessment of Incidence and Factors Associated with Severe Maternal Morbidity after Delivery Discharge among Women in the US. JAMA Network Open, 4, e2036148. https://doi.org/10.1001/jamanetworkopen.2020.36148
[4]
Graves, M., Howse, K., Pudwell, J. and Smith, G.N. (2019) Indicateurs du risque cardiovasculaire liés à la grossesse: Approche des soins de première ligne pour la gestion et la prévention postnatales de maladies futures. Canadian Family Physician, 65, e505-e512.
[5]
Kilpatrick, S.K. and Ecker, J.L. (2016) Severe Maternal Morbidity: Screening and Review. American Journal of Obstetrics and Gynecology, 215, B17-B22. https://doi.org/10.1016/j.ajog.2016.07.050
[6]
Creanga, A.A., Syverson, C., Seed, K. and Callaghan, W.M. (2017) Pregnancy-Related Mortality in the United States, 2011-2013. Obstetrics & Gynecology, 130, 366-373. https://doi.org/10.1097/aog.0000000000002114
[7]
Windram, J. and Siu, S.C. (2021) “Cardio-Obstetrics”: A Burgeoning Field in Need of Increased Awareness, Training, and Collaboration. Canadian Journal of Cardiology, 37, 2076-2079. https://doi.org/10.1016/j.cjca.2021.09.019
[8]
Graves, M., Howse, K., Pudwell, J. and Smith, G.N. (2019) Pregnancy-Related Cardiovascular Risk Indicators. Canadian Journal of Cardiology, 65, 883-889.
[9]
Declercq, E.R., Cabral, H.J., Cui, X., Liu, C., Amutah-Onukagha, N., Larson, E., et al. (2022) Using Longitudinally Linked Data to Measure Severe Maternal Morbidity. Obstetrics & Gynecology, 139, 165-171. https://doi.org/10.1097/aog.0000000000004641
[10]
Thakkar, A., Hameed, A.B., Makshood, M., Gudenkauf, B., Creanga, A.A., Malhamé, I., et al. (2023) Assessment and Prediction of Cardiovascular Contributions to Severe Maternal Morbidity. JACC: Advances, 2, Article 100275. https://doi.org/10.1016/j.jacadv.2023.100275
[11]
Sénégal Division de la lutte contre les MNT (2017) Plan stratégique de lutte contre les mala-dies non transmissibles 2017-2020. DLMNT\MSAS\Sénégal, 77.
[12]
Mbaye, A., Babaka, K., Ngaïde, A.A., Gazal, M., Faye, M., Niang, K., et al. (2018) Prévalence des facteurs de risque cardio-vasculaire en milieu semi-rural au Sénégal. Annales de Cardiologie et d'Angéiologie, 67, 264-269. https://doi.org/10.1016/j.ancard.2018.04.005
[13]
Sénégal Centre de Suivi Ecologique (2020) Rapport sur l’état de l’environnement au Sénégal. CSE\MEDD\Sénégal, 280.
[14]
Nath, A., Sheeba, B., Raj, S. and Metgud, C.S. (2021) Prevalence of Hypertension in Pregnancy and Its Associated Factors among Women Attending Antenatal Clinics in Bengaluru. Journal of Family Medicine and Primary Care, 10, 1621-1627. https://doi.org/10.4103/jfmpc.jfmpc_1520_20
[15]
Ganguly, S. and Begum, A. (2007) Rate of Caesarean Operation and Complications in Hypertensive Disorders of Pregnancy. The Orion Medical Journal, 27, 463-466.
[16]
Callaghan, W.M., Creanga, A.A. and Kuklina, E.V. (2012) Severe Maternal Morbidity among Delivery and Postpartum Hospitalizations in the United States. Obstetrics & Gynecology, 120, 1029-1036. https://doi.org/10.1097/AOG.0b013e31826d60c5
[17]
Regitz-Zagrosek, V., Roos-Hesselink, J.W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., et al. (2018) 2018 ESC Guidelines for the Management of Cardiovascular Diseases during Pregnancy. European Heart Journal, 39, 3165-3241. https://doi.org/10.1093/eurheartj/ehy340
[18]
Umesawa, M. and Kobashi, G. (2016) Epidemiology of Hypertensive Disorders in Pregnancy: Prevalence, Risk Factors, Predictors and Prognosis. Hypertension Research, 40, 213-220. https://doi.org/10.1038/hr.2016.126
[19]
Hafez, S.K., Dorgham, L.S. and Sayed, S.A. (2014) Profile of High Risk Pregnancy among Saudi Women in Taif-KSA. World Journal of Medical Sciences, 11, 90-97.
[20]
Wu, P., Haththotuwa, R., Kwok, C.S., Babu, A., Kotronias, R.A., Rushton, C., et al. (2017) Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circulation: Cardiovascular Quality and Outcomes, 10, e003497. https://doi.org/10.1161/circoutcomes.116.003497
[21]
Magee, L.A., Sharma, S., Nathan, H.L., Adetoro, O.O., Bellad, M.B., Goudar, S., et al. (2019) The Incidence of Pregnancy Hypertension in India, Pakistan, Mozambique, and Nigeria: A Prospective Population-Level Analysis. PLOS Medicine, 16, e1002783. https://doi.org/10.1371/journal.pmed.1002783
[22]
Centers for Disease Control and Prevention (2017) National Diabetes Statistics Report, 2017: Estimates of Diabetes and Its Burden in the United States. CDC, (Level II-3).
[23]
Peterson, C., Grosse, S.D., Li, R., Sharma, A.J., Razzaghi, H., Herman, W.H., et al. (2015) Preventable Health and Cost Burden of Adverse Birth Outcomes Associated with Pregestational Diabetes in the United States. American Journal of Obstetrics and Gynecology, 212, 74.E1-74.E9. https://doi.org/10.1016/j.ajog.2014.09.009
[24]
Britton, L.E., Hussey, J.M., Crandell, J.L., Berry, D.C., Brooks, J.L. and Bryant, A.G. (2018) Racial/Ethnic Disparities in Diabetes Diagnosis and Glycemic Control among Women of Reproductive Age. Journal of Women’s Health, 27, 1271-1277. https://doi.org/10.1089/jwh.2017.6845
[25]
Louis, J.M., Menard, M.K. and Gee, R.E. (2015) Racial and Ethnic Disparities in Maternal Morbidity and Mortality. Obstetrics & Gynecology, 125, 690-694. https://doi.org/10.1097/aog.0000000000000704
